Marketing - Press Releases

Date	Title	Company
15-Jan-2020	Abeona Therapeutics Initiates Pivotal Phase 3 Clinical Trial Evaluating EB-101 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa	Abeona Therapeutics Inc
15-Jan-2020	BioNTech Appoints Ryan Richardson as Chief Strategy Officer to Support its Continued Global Expansion	BioNTech
15-Jan-2020	HRA PHARMA FURTHERS INTERNATIONAL EXPANSION WITH CHINESE JOINT VENTURE	HRA Pharma
15-Jan-2020	XBiotech Commences Tender Offer to Purchase up to $420,000,000 of its Shares	XBiotech
15-Jan-2020	Helsinn appoints Eric Cornut and Lonnie Moulder to the Board of Directors	Helsinn Group
15-Jan-2020	Scottish Medicines Consortium recommends Zytiga® (abiraterone acetate) in combination with prednisone and androgen deprivation therapy (ADT) for men with aggressive, early prostate cancer for use in NHS Scotland	The Janssen Pharmaceutical Companies of Johnson & Johnson
15-Jan-2020	New Research & Development Director to boost product development strategy at Clasado BioSciences	Clasado BioSciences
15-Jan-2020	bluebird bio Announces Launch in Germany of Zynteglo™ (autologous CD34+ cells encoding βA-T87Q-globin gene)	bluebird bio, Inc
15-Jan-2020	Domain Therapeutics secures €6 million ($6.7M) debt financing	Domain Therapeutics
15-Jan-2020	Lynparza regulatory submission granted Priority Review in the US for 1st-line maintenance treatment with bevacizumab in advanced ovarian cancer	AstraZeneca
15-Jan-2020	Pre-close trading update confirms 2019 trading in-line with expectations	Vectura
15-Jan-2020	Independent Panthera Biopartners appoints Stuart Young as CEO as the company further strengthens its team.	Panthera Biopartners
15-Jan-2020	Alliance Healthcare Launches Online Portal	Alliance Healthcare
15-Jan-2020	OGT unveils reliable somatic CNV detection for CLL with new NGS panel	Oxford Gene Technology
15-Jan-2020	Carterra® Closes Financing Round for Continued Growth of the LSA™ Platform for Next Generation Antibody Discovery	Carterra, Inc
15-Jan-2020	Almirall to participate in J.P. Morgan Healthcare Conference in San Francisco	Almirall
15-Jan-2020	Dovato (dolutegravir/lamivudine), the once-daily, single-pill, 2-drug regimen for the treatment of HIV-1 infection, granted marketing approval by Japan Ministry of Health, Labour and Welfare	ViiV Healthcare
15-Jan-2020	Dovato (dolutegravir/lamivudine), the once-daily, single-pill, 2-drug regimen for the treatment of HIV-1 infection, granted marketing approval by Japan Ministry of Health, Labour and Welfare	ViiV Healthcare
15-Jan-2020	The UK and the NHS are providing the right environment and infrastructure to allow innovative cell and gene therapies to reach patients.	The Cell and Gene Therapy Catapult (CGT Catapult)
15-Jan-2020	OPEN Health expands offering with the launch of a new Learning & Development specialist team	OPEN Health